This project is to develop **statistical** tools for analysis of _pharmacokinetic-pharmacodynamic_ (PK-PD) data.



---



`Developed tools`

|`GMAP (7; R)`|`WebNONMEM (R/CGI)`|`SWmcmc (3; R)`|`P-NONMEM (4; R/Perl)`|`psonlme (R)`|`LPSO (R)`|`PKstart (R)`|
|:------------|:------------------|:--------------|:---------------------|:------------|:---------|:------------|



---



_References_

  1. S Kim; L Li. Statistical identifiability for nonlinear mixed effect models using PSO. Submitted.
  1. S Kim; A Gaweda; M Brier; L Li; D Wu. Simplified pharmacodynamic models for wafarin. Clinical Pharmacology and Therapeutics In press.
  1. <a href='http://www3.stat.sinica.edu.tw/statistica/j22n3/j22n312/j22n312.html'>S Kim and L Li. 2012. A Switching Markov Chain Monte Carlo Method for Statistical Identifiability of Nonlinear Pharmacokinetics Models. Statistica Sinica, 22, 1199-1215.</a>
  1. <a href='http://link.springer.com/article/10.1007/s10928-011-9204-6?null'>S Kim and L Li. 2011. A novel global search algorithm on non-liner mixed-effect models using particle swarm optimization. Journal of Pharmacokinetics and Pharmacodynamics, 38, 471-95.</a>
  1. <a href='http://www.nature.com/clpt/journal/v89/n1s/pdf/clpt2010333a.pdf'>S.Kim, L.Li. 2011. Bayesian Monte Carlo Markov Chain (MCMC) two-stage approaches on non-linear mixed-effect pharmacokinetic models, Clinical Pharmacology and Therapeutics 89, P. S66, OIII-A-3.</a>
  1. <a href='http://www.nature.com/clpt/journal/v87/n1s/pdf/clpt2009274a.pdf'>S. Kim, L. Li. 2010. A global search and numerical identifiability algorithm, Clinical Pharmacology and Therapeutics 87, p. S64, PII-79.</a>
  1. <a href='http://www.tandfonline.com/doi/full/10.1080/10543400902964159'>S Kim, S. D. Hall, and L Li. 2009. A Novel Gibbs Maximum a Posteriori (GMAP) Methods on Bayesian Nonlinear Mixed-Effects Pharmacokinetic (PK) Models.  Journal of Biopharmaceutical Statistics, 19, 700-720.</a>
  1. <a href='http://www.nature.com/clpt/journal/v85/n1s/pdf/clpt2008283a.pdf'>S. Kim, L. Li. 2009. “Numerical identifiability and convergence for Bayesian Monte Carlo Markov chain (MCMC) methods of nonlinear pharmacokinetics (PK) models," Clinical Pharmacology and Therapeutics 85, p. S28, PI-64.</a>
  1. <a href='http://www.nature.com/clpt/journal/v83/n1s/pdf/clpt200836a.pdf'>S. Kim, S. D. Hall, and L. Li. 2008. “Monte Carlo Markov Chain Methods on Bayesian Nonlinear Mixed-Effects Pharmacokinetic (PK) Models," Clinical Pharmacology and Therapeutics 83, p. S7, PT-17.</a>